Literature DB >> 16801938

Genetic diversity and function in the human cytosolic sulfotransferases.

M A T Hildebrandt1, D P Carrington, B A Thomae, B W Eckloff, D J Schaid, V C Yee, R M Weinshilboum, E D Wieben.   

Abstract

Amino-acid substitutions, which result from common nonsynonymous (NS) polymorphisms, may dramatically alter the function of the encoded protein. Gaining insight into how these substitutions alter function is a step toward acquiring predictability. In this study, we incorporated gene resequencing, functional genomics, amino-acid characterization and crystal structure analysis for the cytosolic sulfotransferases (SULTs) to attempt to gain predictability regarding the function of variant allozymes. Previously, four SULT genes were resequenced in 118 DNA samples. With additional resequencing of the remaining eight SULT family members in the same DNA samples, a total of 217 polymorphisms were revealed. Of 64 polymorphisms identified within 8785 bp of coding regions from SULT genes examined, 25 were synonymous and 39 were NS. Overall, the proportion of synonymous changes was greater than expected from a random distribution of mutations, suggesting the presence of a selective pressure against amino-acid substitutions. Functional data for common variants of five SULT genes have been previously published. These data, together with the SULT1A1 variant allozyme data presented in this paper, showed that the major mechanism by which amino acid changes altered function in a transient expression system was through decreases in immunoreactive protein rather than changes in enzyme kinetics. Additional insight with regard to mechanisms by which NS single nucleotide polymorphisms alter function was sought by analysis of evolutionary conservation, physicochemical properties of the amino-acid substitutions and crystal structure analysis. Neither individual amino-acid characteristics nor structural models were able to accurately and reliably predict the function of variant allozymes. These results suggest that common amino-acid substitutions may not dramatically alter the protein structure, but affect interactions with the cellular environment that are currently not well understood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16801938     DOI: 10.1038/sj.tpj.6500404

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  17 in total

Review 1.  The pharmacogenetics research network: from SNP discovery to clinical drug response.

Authors:  K M Giacomini; C M Brett; R B Altman; N L Benowitz; M E Dolan; D A Flockhart; J A Johnson; D F Hayes; T Klein; R M Krauss; D L Kroetz; H L McLeod; A T Nguyen; M J Ratain; M V Relling; V Reus; D M Roden; C A Schaefer; A R Shuldiner; T Skaar; K Tantisira; R F Tyndale; L Wang; R M Weinshilboum; S T Weiss; I Zineh
Journal:  Clin Pharmacol Ther       Date:  2007-03       Impact factor: 6.875

2.  Glutathione s-transferase p1: gene sequence variation and functional genomic studies.

Authors:  Ann M Moyer; Oreste E Salavaggione; Tse-Yu Wu; Irene Moon; Bruce W Eckloff; Michelle A T Hildebrandt; Daniel J Schaid; Eric D Wieben; Richard M Weinshilboum
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

3.  Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomics.

Authors:  Kendra K S Nordgren; Yi Peng; Linda L Pelleymounter; Irene Moon; Ryan Abo; Qiping Feng; Bruce Eckloff; Vivien C Yee; Eric Wieben; Richard M Weinshilboum
Journal:  Drug Metab Dispos       Date:  2011-08-03       Impact factor: 3.922

4.  Sulfation of ritodrine by the human cytosolic sulfotransferases (SULTs): Effects of SULT1A3 genetic polymorphism.

Authors:  Ying Hui; Ming-Cheh Liu
Journal:  Eur J Pharmacol       Date:  2015-05-02       Impact factor: 4.432

5.  Effects of the human SULT1A1 polymorphisms on the sulfation of acetaminophen,O-desmethylnaproxen, and tapentadol.

Authors:  Mohammed I Rasool; Ahsan F Bairam; Saud A Gohal; Amal A El Daibani; Fatemah A Alherz; Maryam S Abunnaja; Eid S Alatwi; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Pharmacol Rep       Date:  2018-12-10       Impact factor: 3.024

6.  Thiopurine S-methyltransferase pharmacogenetics: functional characterization of a novel rapidly degraded variant allozyme.

Authors:  Qiping Feng; Suda Vannaprasaht; Yi Peng; Susothorn Angsuthum; Yingyos Avihingsanon; Vivien C Yee; Wichittra Tassaneeyakul; Richard M Weinshilboum
Journal:  Biochem Pharmacol       Date:  2009-11-27       Impact factor: 5.858

7.  Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT "pie".

Authors:  Zoe Riches; Emma L Stanley; Jackie C Bloomer; Michael W H Coughtrie
Journal:  Drug Metab Dispos       Date:  2009-08-13       Impact factor: 3.922

Review 8.  SULT genetic polymorphisms: physiological, pharmacological and clinical implications.

Authors:  Katsuhisa Kurogi; Mohammed I Rasool; Fatemah A Alherz; Amal A El Daibani; Ahsan F Bairam; Maryam S Abunnaja; Shin Yasuda; Lauren J Wilson; Ying Hui; Ming-Cheh Liu
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-06-30       Impact factor: 4.936

9.  Does rapid metabolism ensure negligible risk from bisphenol A?

Authors:  Gary Ginsberg; Deborah C Rice
Journal:  Environ Health Perspect       Date:  2009-07-14       Impact factor: 9.031

10.  Bioactivation of the human carcinogen aristolochic acid.

Authors:  Viktoriya S Sidorenko; Sivaprasad Attaluri; Irina Zaitseva; Charles R Iden; Kathleen G Dickman; Francis Johnson; Arthur P Grollman
Journal:  Carcinogenesis       Date:  2014-04-17       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.